to reduce the chance of kidney disease worsening, kidney failure (conclusion-phase kidney disease), and death resulting from heart problems in Older people with type 2 diabetes and chronic kidney disease to lessen the risk of key cardiovascular gatherings for instance coronary heart attack, stroke, or death in Older people with type two diabetic